Home/Filings/4/0000950170-25-062937
4//SEC Filing

Gross Jane A 4

Accession 0000950170-25-062937

CIK 0001339970other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 5:20 PM ET

Size

5.3 KB

Accession

0000950170-25-062937

Insider Transaction Report

Form 4
Period: 2025-05-01
Gross Jane A
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-05-01+50,00050,000 total
    Exercise: $3.34Exp: 2035-05-01Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

Documents

1 file

Issuer

aTYR PHARMA INC

CIK 0001339970

Entity typeother

Related Parties

1
  • filerCIK 0001684258

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:20 PM ET
Size
5.3 KB